ANDREW C KIM
- Type
- Physician · Allopathic & Osteopathic Physicians / Orthopaedic Surgery
- Where
- ARCATA, CA
- NPI
- 1609978618
- Received
- $1,745 in 14 records, 2019 to 2025
- As principal investigator
- $404,297 of research payments to others in 42 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 2 | $134 |
| 2024 | General payment | 2 | $77 |
| 2023 | General payment | 2 | $87 |
| 2021 | General payment | 3 | $1,345 |
| 2020 | General payment | 2 | $38 |
| 2019 | General payment | 3 | $63 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ImpactOrtho, Inc. | 1 | $1,200 | 2021 |
| Medical Device Business Services, Inc. | 4 | $164 | 2023–2024 |
| Zimmer Biomet Holdings, Inc. | 2 | $134 | 2025 |
| AstraZeneca Pharmaceuticals LP | 1 | $126 | 2021 |
| PFIZER INC. | 5 | $102 | 2019–2020 |
| Medtronic, Inc. | 1 | $18 | 2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Education | 3 | $1,334 |
| Food and Beverage | 11 | $411 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-06-21 | Zimmer Biomet Holdings, Inc. | $67 | Education | In-kind items and services | OXFORD PARTIAL KNEE Device, Knees | 2025 | |
| 2025-06-20 | Zimmer Biomet Holdings, Inc. | $67 | Education | In-kind items and services | Oxford Device, Knees | 2025 | |
| 2024-02-14 | Medical Device Business Services, Inc. | $40 | Food and Beverage | In-kind items and services | INHANCE Device, Ortho-Shoulder | 2024 | |
| 2024-02-14 | Medical Device Business Services, Inc. | $36 | Food and Beverage | In-kind items and services | INHANCE Device, Ortho-Shoulder | 2024 | |
| 2023-03-09 | Medical Device Business Services, Inc. | $29 | Food and Beverage | In-kind items and services | INHANCE Device, Ortho-Shoulder | 2023 | |
| 2023-03-08 | Medical Device Business Services, Inc. | $57 | Food and Beverage | In-kind items and services | ACTIS Device, Ortho-Hip | 2023 | |
| 2021-11-11 | AstraZeneca Pharmaceuticals LP | $126 | Food and Beverage | In-kind items and services | BREZTRI Drug, Respiratory | 2021 | |
| 2021-03-31 | Medtronic, Inc. | $18 | Food and Beverage | In-kind items and services | Reveal LINQ Device, Cardiac Diagnostics and Monitoring | 2021 | |
| 2021-03-10 | ImpactOrtho, Inc. | $1,200 | Education | In-kind items and services | 2021 | ||
| 2020-02-25 | PFIZER INC. | $25 | Food and Beverage | In-kind items and services | CHANTIX Drug, NEUROSCIENCE;TOBACCO DEPENDENCE | 2020 | |
| 2020-02-04 | PFIZER INC. | $12 | Food and Beverage | In-kind items and services | FLECTOR Drug, INFLAMMATION;PAIN | 2020 | |
| 2019-08-07 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | EMBEDA Drug, NEUROSCIENCE;PAIN | 2019 | |
| 2019-03-19 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | CHANTIX Drug, NEUROSCIENCE;TOBACCO DEPENDENCE | 2019 | |
| 2019-02-07 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2019 |
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-12-12 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $3,870 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-11-19 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $5,160 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-11-07 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $4,362 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-11-03 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $1,325 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-10-10 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $2,325 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-09-19 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $9,498 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-08-25 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $7,030 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-08-13 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $4,598 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-07-23 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $1,626 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-06-23 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $1,626 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-06-20 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $9,924 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-05-21 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $5,208 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-04-23 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $1,368 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-03-21 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $8,847 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-02-19 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $6,736 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-01-22 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $10,207 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2024-12-16 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $9,319 | 70033093AFL3002 | 2024 |
| 2024-11-20 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $6,805 | 70033093AFL3002 | 2024 |
| 2024-11-13 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $4,340 | 70033093AFL3002 | 2024 |
| 2024-10-23 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $2,736 | 70033093AFL3002 | 2024 |
| 2024-09-18 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $8,130 | 70033093AFL3002 | 2024 |
| 2024-08-19 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $8,319 | 70033093AFL3002 | 2024 |
| 2024-07-26 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $5,169 | 70033093AFL3002 | 2024 |
| 2024-06-25 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $6,369 | 70033093AFL3002 | 2024 |
| 2024-06-14 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $12,119 | 70033093AFL3002 | 2024 |
| 2024-06-07 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $6,302 | 70033093AFL3002 | 2024 |
| 2024-05-22 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $7,303 | 70033093AFL3002 | 2024 |
| 2024-04-26 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $2,582 | 70033093AFL3002 | 2024 |
| 2024-03-25 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $8,534 | 70033093AFL3002 | 2024 |
| 2024-03-04 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $29,964 | 70033093AFL3002 | 2024 |
| 2024-01-26 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $35,988 | 70033093AFL3002 | 2024 |
| 2023-12-20 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $5,483 | 70033093AFL3002 | 2023 |
| 2023-12-15 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $15,504 | 70033093AFL3002 | 2023 |
| 2023-11-17 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $10,690 | 70033093AFL3002 | 2023 |
| 2023-10-25 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $13,211 | 70033093AFL3002 | 2023 |
| 2023-09-22 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $3,834 | 70033093AFL3002 | 2023 |
| 2023-09-15 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $30,094 | 70033093AFL3002 | 2023 |
| 2023-08-16 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $45,876 | 70033093AFL3002 | 2023 |
| 2023-07-26 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $4,949 | 70033093AFL3002 | 2023 |
| 2023-07-10 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $225 | 70033093AFL3002 | 2023 |
| 2023-06-27 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $12,203 | 70033093AFL3002 | 2023 |
| 2023-06-16 | Janssen Research & Development, LLC | Allegiance Rsrch Specialists, Llc | $24,539 | 70033093AFL3002 | 2023 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Arcata, CA, county Humboldt County, CA, state California; placed by its city name.
| Measure | Place (city or town) Arcata, CA | County Humboldt County, CA | State California |
|---|---|---|---|
| Population B01003 | 18,607 | 134,541 | 39,287,377 |
| Population, 2020 census P1 | 18,857 | 136,463 | 39,538,223 |
| Median age B01002 | 28.1 | 39.9 | 37.9 |
| Under 18 B01001 | 11.8% | 18.8% | 22.0% |
| 65 and over B01001 | 14.2% | 19.8% | 15.7% |
| Households B11001 | 7,884 | 54,922 | 13,548,091 |
| Foreign born B05002 | 4.6% | 6.2% | 27.0% |
| Median household income B19013 | $46,713 | $61,160 | $99,122 |
| Median family income B19113 | $91,661 | $83,067 | $113,346 |
| Per capita income B19301 | $32,307 | $36,080 | $49,513 |
| Poverty rate B17001 | 27.2% | 18.7% | 12.0% |
| Unemployment rate B23025 | 11.9% | 9.0% | 6.6% |
| Civilian labor force B23025 | 10,541 | 63,659 | 20,068,466 |
| Mean commute (minutes) B08013 | 17.8 | 19.0 | 28.7 |
| Bachelor's degree or higher B15003 | 46.3% | 33.1% | 37.1% |
| Housing units B25001 | 8,636 | 62,883 | 14,644,735 |
| Owner-occupied B25003 | 36.4% | 56.5% | 55.9% |
| Renters B25003 | 63.6% | 43.5% | 44.1% |
| Median home value B25077 | $484,600 | $446,900 | $734,700 |
| Median gross rent B25064 | $1,327 | $1,287 | $2,036 |
| White, not Hispanic B03002 | 70.6% | 69.5% | 33.8% |
| Black B03002 | 3.0% | 1.3% | 5.2% |
| Hispanic or Latino B03002 | 16.0% | 14.2% | 40.2% |
| Asian B03002 | 1.1% | 3.0% | 15.3% |
| American Indian and Alaska Native B03002 | 0.8% | 3.1% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Arcata, CA.
Comments